3.20
4.58%
0.14
Handel nachbörslich:
3.18
-0.02
-0.63%
Finanzdaten der Anixa Biosciences Inc-Aktie (ANIX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-04-30 | 2024-01-31 | 2023-10-31 | 2023-07-31 | 2023-04-30 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | 0.21 |
Research and Development |
22.02%
1.646
|
1.349 | - | - | - |
Costs And Expenses |
3.93%
3.467
|
3.609 | 3.051 | 2.844 | 2.77 |
Operating Income/Loss |
3.93%
-3.467
|
-3.609 | -3.051 | -2.844 | -2.56 |
Income/Loss From Continuing Operations Before Tax |
3.34%
-3.18
|
-3.29 | -2.721 | -2.548 | -2.307 |
Income/Loss From Continuing Operations After Tax |
3.34%
-3.18
|
-3.29 | -2.721 | -2.548 | -2.307 |
Net Income/Loss
|
3.34%
-3.18
|
-3.29 | -2.721 | -2.548 | -2.307 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
17.14%
-0.041
|
-0.035 | -0.031 | -0.037 | -0.019 |
Basic Average Shares |
1.49%
0.0319
|
0.0314 | 0.000039 | 0.031 | - |
Diluted Average Shares |
1.49%
0.0319
|
0.0314 | 0.000039 | 0.031 | 0.0309 |
Basic Earnings Per Share |
200.00%
-0.10
|
0.10 | 0.55 | -0.08 | -0.07 |
Diluted Earnings Per Share |
200.00%
-0.10
|
0.10 | 0.55 | -0.08 | - |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):